Cytek Biosciences (CTKB)
(Delayed Data from NSDQ)
$5.29 USD
+0.23 (4.55%)
Updated Sep 19, 2024 04:00 PM ET
After-Market: $5.28 -0.01 (-0.19%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth A Momentum B VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/5/24 |
---|---|
Current Quarter | -0.01 |
EPS Last Quarter | -0.08 |
Last EPS Surprise | -166.67% |
ABR | 1.67 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.11 |
Next Year | 0.03 |
EPS (TTM) | -0.05 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 51.86M | 62.73M | 204.60M | 240.67M |
# of Estimates | 5 | 5 | 4 | 3 |
High Estimate | 53.43M | 66.70M | 206.45M | 246.48M |
Low Estimate | 49.32M | 60.50M | 202.70M | 236.20M |
Year ago Sales | 48.00M | 58.23M | 193.01M | 204.60M |
Year over Year Growth Est. | 8.05% | 7.72% | 6.00% | 17.63% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.01 | 0.03 | -0.11 | 0.03 |
# of Estimates | 2 | 2 | 2 | 2 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | 0.01 | 0.04 | -0.07 | 0.08 |
Low Estimate | -0.03 | 0.02 | -0.14 | -0.03 |
Year ago EPS | 0.01 | 0.07 | 0.10 | -0.11 |
Year over Year Growth Est. | -200.00% | -57.14% | -210.00% | 118.18% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 1 | 2 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.01 | 0.03 | -0.11 | 0.03 |
7 Days Ago | -0.01 | 0.03 | -0.11 | 0.03 |
30 Days Ago | -0.01 | 0.04 | -0.11 | 0.03 |
60 Days Ago | -0.01 | 0.05 | -0.05 | 0.03 |
90 Days Ago | 0.00 | 0.04 | -0.02 | 0.03 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.01 | 0.03 | -0.11 | 0.03 |
Zacks Consensus Estimate | -0.01 | 0.03 | -0.11 | 0.03 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.08 | -0.05 | 0.07 | 0.01 | NA |
Estimate | -0.03 | -0.05 | 0.03 | 0.02 | NA |
Difference | -0.05 | 0.00 | 0.04 | -0.01 | -0.01 |
Surprise | -166.67% | 0.00% | 133.33% | -50.00% | -20.84% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more